Clinical Trial Update: High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating high-resolution assessment of extracranial plaques in a multicenter evolocumab study for cerebral atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Atherosclerosis

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Cerebral Atherosclerosis | Phase 4 | Status: UNKNOWN